Human trials on peptides like Selank remain small, short in duration, and largely conducted outside the U.S., which limits how confidently the results generalize
Combination effects
Based on the analysis above, despite the requirement of more clinical evidence, existing data has indicated the potential prospect for the use of GLP-1 and its analogues in AD treatment in the future (81)
On the other hand, this method of shared decision-making represents a standard practice in clinical settings, offering a valuable insight into real-world scenarios
Thats why semaglutides have been used for several years to treat type 2 diabetes
So, by delaying its breakdown, GLP-1 stays in your body longer, helping lower blood sugar levels